Previous 10 | Next 10 |
Volatility remains the dominant factor across the equities market, with interest rates rising and growth stocks well underwater so far in 2022. Ground zero for this correction is among “long duration assets”, which includes growth stocks with big hypothetical cash flows down the...
The major U.S. equity averages finished Wednesday's session lower, halting a rally that has marked most of the past two weeks. The Nasdaq led the retreat with a decline of 1.2%. Regional banks were among the losers on the day. A flattening yield curve has raised concerns about bank profits. S...
Adagio Therapeutics, Inc. (NASDAQ: ADGI) reports primary endpoints were met with statistical significance for all three indications of the company’s ongoing Phase 2/3 clinical trials evaluating its drug adintrevimab as a pre-and-post exposure prophylaxis and treatment f...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (NASDAQ: MRNA ) stock is on the move this week after the Centers for Disease Control and Prevention (CDC) updated Covid-19 booster shot recommendations. Source: guteksk7 / Shutterstock.com The CDC is n...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virgin Galactic (NYSE: SPCE ) stock has been on the upward trend this week and we’re going over all the recent news affecting the shares. Source: Tun Pichitanon / Shutterstock.com The first bit of news wo...
Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clinical-stage biopharmaceutical company Adagio Therapeutics (NASDAQ: ADGI ) is soaring today on news it will pursue authorization for its Covid-19 antibody treatment. ADGI stock is up a stunning 43% so far today. ...
Shares of Adagio Therapeutics (NASDAQ: ADGI) , a clinical-stage biopharmaceutical company, are shooting higher on Wednesday morning in response to new clinical trial data. Investors amped up about the results pushed the stock 42% higher as of 10:26 a.m. ET on Wednesday. Adagio T...
Gainers: Adagio Therapeutics (ADGI) +48%. Vyant Bio (VYNT) +23%. Vir Biotechnology (VIR) +19%. Sonoma Pharmaceuticals (SNOA) +15%. Syros Pharmaceuticals (SYRS) +15%. Losers: Revelation Biosciences (REVB) -40%. UpHealth (UPH) -29%. The Valens (VLNS)...
Buying Penny Stocks Today? Here’s What You Need to Know Buying penny stocks in 2022 is not for the faint of heart. With so much going on in the stock market, trading penny stocks and blue chips in the last few weeks has been extremely volatile, to say the least. And although ...
News, Short Squeeze, Breakout and More Instantly...
Adagio Therapeutics Inc. Company Name:
ADGI Stock Symbol:
NASDAQ Market:
WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that as part of the annual reconstitution of the Russell stock indexes, Invivyd will be included in ...
Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current dominant strains and the most recent FLiRT-containing viruses Invivyd’s new data is...
WALTHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that its management team is scheduled to participate in a fireside chat at the Jefferies Global Heal...